| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Curt Bradshaw last filed a Form 4 in November 2020, as Chief Scientific Officer at ARWR. Curt Bradshaw's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Curt Bradshaw has 1 Form 4 filing on record in November 2020, as Chief Scientific Officer at Arrowhead Pharmaceuticals (ARWR), 2020.
The 2 reported transactions were 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $2.2M.
The only open-market sale was 31,250 shares of ARWR at an average $69.06 on November 20, 2020, about $2.2M.
Shares as reported in the last Form 4 for each company; the most recent is from November 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 31,250 | $69.06 | $2,158,125.00 | -100% |